K63.82
Intestinal microbial overgrowth
Clinical Classification Guidelines
Medical Intelligence & Overview
Intestinal microbial overgrowth, also known as small intestinal bacterial overgrowth (SIBO), is a condition where there is an abnormal increase in the number or type of bacteria in the small intestine. Normally, the small intestine contains fewer bacteria compared to the large intestine. When this balance is disrupted, it can lead to symptoms and nutrient absorption issues. Recognizing and managing this condition is important for maintaining digestive health.
Causes & Symptoms
Clinical Causes: Delayed stomach emptying (gastroparesis) Structural abnormalities in the small intestine, such as strictures or diverticula Impaired immune system function Use of certain medications, especially antibiotics and acid-suppressing drugs Chronic digestive conditions, like Crohn's disease or celiac disease Neurological disorders affecting intestinal motility Surgical alterations of the gastrointestinal tract
Key Symptoms: Bloating and abdominal distension Gas and belching Diarrhea or sometimes constipation Abdominal pain or discomfort Unintentional weight loss Malnutrition and deficiencies of vitamins and minerals Fatigue
Diagnostic & Treatment
Diagnosis Path: Diagnosing intestinal microbial overgrowth typically involves several steps. Medical providers may conduct breath tests, such as the hydrogen or methane breath test, which measures gases produced by bacteria in the small intestine after consuming a sugar solution. Blood tests, stool analyses, and imaging studies might also be used to rule out other conditions and confirm the diagnosis. A detailed medical history and symptom assessment are essential components of the evaluation.
Treatment Protocols: Treating intestinal microbial overgrowth generally involves a combination of approaches. Antibiotics, such as rifaximin, are commonly prescribed to reduce bacterial overgrowth. Dietary modifications, like a low FODMAP diet or specific carbohydrate restriction, can help alleviate symptoms. Addressing underlying causes, such as improving gastrointestinal motility or managing structural issues, is also crucial. In some cases, probiotics or other medications may be recommended to restore healthy gut flora. Regular follow-up and testing are often necessary to monitor progress and prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is K63.82 a billable ICD-10 code?
Yes, K63.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K63.82?
Clinical documentation must specify the nature of Intestinal microbial overgrowth and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
